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Abstract 
Background: Following partial injury to the central nervous system, cells beyond the initial injury site undergo 
secondary degeneration, exacerbating loss of neurons, compact myelin and function. Changes in  Ca2+ flux are associ-
ated with metabolic and structural changes, but it is not yet clear how flux through specific ion channels contributes 
to the various pathologies. Here, partial optic nerve transection in adult female rats was used to model secondary 
degeneration. Treatment with combinations of three ion channel inhibitors was used as a tool to investigate which 
elements of oxidative and structural damage related to long term functional outcomes. The inhibitors employed were 
the voltage gated  Ca2+ channel inhibitor Lomerizine (Lom), the  Ca2+ permeable AMPA receptor inhibitor YM872 and 
the  P2X7 receptor inhibitor oxATP.
Results: Following partial optic nerve transection, hyper-phosphorylation of Tau and acetylated tubulin immuno-
reactivity were increased, and Nogo-A immunoreactivity was decreased, indicating that axonal changes occurred 
acutely. All combinations of ion channel inhibitors reduced hyper-phosphorylation of Tau and increased Nogo-A 
immunoreactivity at day 3 after injury. However, only Lom/oxATP or all three inhibitors in combination significantly 
reduced acetylated tubulin immunoreactivity. Most combinations of ion channel inhibitors were effective in restoring 
the lengths of the paranode and the paranodal gap, indicative of the length of the node of Ranvier, following injury. 
However, only all three inhibitors in combination restored to normal Ankyrin G length at the node of Ranvier. Similarly, 
HNE immunoreactivity and loss of oligodendrocyte precursor cells were only limited by treatment with all three ion 
channel inhibitors in combination.
Conclusions: Data indicate that inhibiting any of a range of ion channels preserves certain elements of axon and 
node structure and limits some oxidative damage following injury, whereas ionic flux through all three channels must 
be inhibited to prevent lipid peroxidation and preserve Ankyrin G distribution and OPCs.
Keywords: Secondary degeneration, Neurotrauma, Traumatic injury, Ion channel inhibitor, Axonal degeneration, 
Node of Ranvier, Lipid peroxidation, Oligodendrocyte precursor cells, Oxidative stress
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Background
Following trauma to the central nervous system 
(CNS), cells beyond the initial injury site succumb to 
degenerative events in a series of sequelae referred to 
as secondary degeneration. Secondary degeneration 
of white matter adjacent to a primary injury and vul-
nerable to damage can be modelled by partial transec-
tion of the optic nerve, where axons in the dorsal optic 
nerve are axotomised by the primary injury and ventral 
optic nerve is initially intact but vulnerable to secondary 
degeneration [1, 2]. Tracing of optic nerve axons using 
fluorescent dyes applied to ventral retina illustrates that 
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ventral axons remain intact in the early stages following 
the partial transection [2]. Changes in  Ca2+ flux occur 
following neurotrauma [3], and in optic nerve vulnerable 
to secondary degeneration following partial transection 
[4, 5]. Altered  Ca2+ flux is associated with increased reac-
tive oxygen species (ROS), enhanced anti-oxidant activ-
ity, and oxidative damage to DNA, protein and lipid in 
the first minutes and days following injury [6–8]. Cyto-
solic  Ca2+ concentrations increase via influx from extra-
cellular pools, and also via  Ca2+-mediated release from 
intracellular stores [9, 10].  Ca2+ enters cells of the CNS 
through a range of channels and receptors, including but 
not limited to: voltage-gated  Ca2+ channels (VGCCs) 
[11]; purinergic  P2X7 receptors  (P2X7Rs) [12]; and  Ca2+ 
permeable ionotropic α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptors (AMPARs) [13]. Intra-
cellular levels of  Ca2+ are typically low in neurons and 
glia, however excessive depolarization of neurons via glu-
tamate excitotoxicity [14, 15] promotes intracellular  Ca2+ 
influx through VGCCs [16]. Increasing extracellular ATP 
concentrations are also a typical consequence of injury 
[17], leading to increased  Ca2+ flux through  P2X7Rs [18].
Ca2+ influx following axonal injury activates deleteri-
ous cascades which induce the breakdown of cytoskeletal 
proteins and disruption of axonal transport, often leading 
to degeneration and neuronal death. Tau is a cytoskel-
etal phosphoprotein and although dynamic, site-specific 
phosphorylation of Tau is essential for its proper func-
tioning, inappropriate and or hyper-phosphorylation 
at tyrosine 205 (Tau  [pT205]), serine 262 (Tau  [pS262]) 
and serine 396 (Tau  [pS396]) [19, 20] renders it toxic and 
results in impaired microtubule assembly, disruption of 
anterograde and retrograde axonal transport and calpain 
mediated cell death [20–23]. The microtubule protein 
tubulin is acetylated in an activity-dependent manner 
via  Ca2+ influx [24]. Reductions in acetylated tubulin are 
associated with Alzheimer’s disease and Parkinson’s dis-
ease [25, 26], and it is argued that tubulin acetylation may 
be a consequence of, rather than contributor to, micro-
tubule stability. Limiting  Ca2+ influx is neuroprotective 
via maintenance of the integrity of cytoskeletal proteins, 
however it is not known which cytoskeletal elements 
are essential for maintenance of axonal integrity, myelin 
structure and long term function following injury [27], 
and the timing of disruptions to axonal proteins during 
secondary degeneration is not yet clear.
Following injury, distribution of node of Ranvier and 
paranode proteins is also disrupted, contributing to func-
tional impairment [28]. Caspr localization changes with 
spinal cord injury, with aberrant overlapping of Caspr, 
Kv1.1 and Kv1.2 in the paranodal regions [29]. Paranodal 
unfurling and lengthening of the paranode and paranodal 
gap are observed at 1 and 3 days as well as chronic time 
points in white matter vulnerable to secondary degenera-
tion [30]. Myelin disruption is linked to its vulnerability 
to secondary events such as energy depletion, excitotox-
icity [31], over-production of ROS and lipid peroxidation 
[32], which are elevated in optic nerve vulnerable to sec-
ondary degeneration [6]. Myelinating oligodendrocytes 
and oligodendrocyte precursor cells (OPCs) are particu-
larly sensitive to excitotoxic insult and oxidative stress, 
with greater sensitivity of progenitor cells [33]. Early OPC 
proliferative responses and OPC depletion from 7  days 
are features of secondary degeneration [34], associated 
with myelin decompaction detected by electron micros-
copy from 3 months [35, 36]. However, mature oligoden-
drocyte numbers are maintained at relatively constant 
levels throughout [34]. The oligodendrocyte membrane 
protein NogoA is an inhibitor of axonal regeneration, 
located predominantly in the innermost and outer myelin 
membranes [37]. Studies demonstrate variable changes in 
the expression of NogoA following injury, with increases 
and decreases depending upon injury model and timing 
[38–40]. NogoA dynamics in secondary degeneration are 
unknown, yet the dynamic variation in NogoA expres-
sion could potentially explain different regenerative 
phenotypes and lack of a consistent therapeutic effect of 
NogoA inhibition [41].
Given the consequences of excessive  Ca2+ during sec-
ondary degeneration, limiting  Ca2+ entry into cells is 
hypothesized to reduce oxidative stress, and disruptions 
to axonal and myelin structure. The administration of 
single  Ca2+ channel inhibitors have been used as a thera-
peutic strategy for CNS injury in vivo, reviewed in [42]. 
Whilst promising results have been demonstrated in 
pre-clinical studies, clinical trials have been disappoint-
ing [43, 44]. Given the multiple routes of entry of  Ca2+ 
in the CNS, it is increasingly understood that a combi-
natorial approach to therapy, involving inhibition of mul-
tiple channels through which  Ca2+ can pass, is likely to 
be required. We have previously assessed the efficacy 
of various combinations of three ion channel inhibitors 
for treatment of secondary degeneration: using lom-
erizine hydrochloride (Lom) [45], zonampanel mono-
hydrate YM872 [46, 47] (also referred to as INQ) and/
or oxidized ATP (oxATP) [48] to inhibit VGCCs,  Ca2+ 
permeable AMPARs and  P2X7Rs, respectively. We have 
demonstrated that the three ion channel inhibitors in 
combination were required to preserve myelin compac-
tion, node of Ranvier length and behavioural function, 
in optic nerve vulnerable to secondary degeneration in 
the chronic phase, 3 months following injury [49]. How-
ever, in the acute phase after injury, it is not yet known 
whether ionic flux through particular channels is asso-
ciated specifically with oxidative stress, axon degenera-
tion, altered nodes and/or OPC loss. Here we used the 
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partial optic nerve transection model and assessed early 
cytoskeletal protein and Nogo-A changes in the first 
week after injury. In vivo administration of various com-
binations of the three ion channel inhibitors was used 
as a tool to determine the relative importance of influx 
of extracellular ions through specific channels, for acute 
disruptions to visual behaviour, axon and node of Ranvier 
structure, oxidative stress and OPC numbers. Outcomes 
of inhibitor treatment were assessed at three days follow-
ing injury as this is a time point known to feature oxida-
tive damage, nodal disruptions and OPC responses in 
nerve vulnerable to secondary degeneration [30, 34], and 
were related to chronic rescue of myelin structure and 
function by the inhibitors in this model [49]. Outcome 
measures were confined to those known to change in the 
early phase of injury rather than those that appear chron-
ically; an immunohistochemistry based approach was 
employed to enable assessment of cell numbers, struc-
tural components and cell-specific responses to injury.
Methods
Animals, anaesthesia and surgery
Female Piebald Virol Glaxo (PVG) adult rats (160–200 g), 
obtained from the Animal Resource Centre (Murdoch, 
Western Australia), were housed in groups of three under 
standard conditions including 12  h (h) light/dark cycles 
and ad libitum access to chow and water. All procedures 
were carried out in accordance with National Institutes 
of Health guide for the care and use of Laboratory ani-
mals (NIH Publications No. 8023, revised 1978) and 
approved by The University of Western Australia Animal 
Ethics Committee, Approval No. RA3/100/673. Female 
rats were used in order to complement our body of work 
on secondary degeneration following partial optic nerve 
transection in female PVG rats [6, 35, 49, 50]. Using a 
single sex of animals minimises variability due to sex 
specific differences and female animals can readily be 
group housed, making them convenient to work with. 
Anaesthesia was administered intraperitoneally (i.p.) 
as a combination of Xylazine (Ilium Xylazil 20, 10  mg/
kg, Troy Laboratories) and Ketamine (Ketamil, 50  mg/
kg, Troy Laboratories). Partial transection of the optic 
nerve, in which retinal ganglion cell (RGC) axons in the 
dorsal aspect of the optic nerve are lesioned leaving those 
on the ventral side intact but susceptible to secondary 
degeneration, was conducted as described previously 
[50]. Briefly, the dorsal side of the right optic nerve was 
partially transected approximately 1 mm behind the eye, 
to a controlled depth of 200 µm using a diamond radial 
keratotomy knife (Geuder). Post-operative analgesia was 
administered subcutaneously (2.8 mg/kg carprofen, Nor-
brook). Control animals were uninjured normal animals, 
as sham injured animals have been shown to be no differ-
ent to normal in terms of visual function, RGC numbers 
and other cellular parameters [50]. Animals were eutha-
nized with Euthal (active constituents Pentobarbitone 
Sodium 170  mg/mL, Phenytoin Sodium 25  mg/mL) at 
days 1, 3 or 7 post surgery.
Treatments
Animals were randomly allocated into groups within 
three separate cohorts (described below) for testing 
of combinations of the three  Ca2+ channel inhibitors, 
lomerizine (Lom; LKT Laboratories), OxATP (Sigma-
Aldrich) and/or YM872 (LKT Laboratories). Treatment 
began on the day of surgery after full recovery from 
anaesthesia. Choices of treatment concentrations, routes 
and durations were based on previously published stud-
ies showing efficacy using these agents individually. Lom 
was administered orally twice daily in butter (30 mg/kg) 
[45]; all animals not receiving Lom received butter vehi-
cle. OxATP (1  mM; Matute et  al. [49]) and/or YM872 
(240  µM) were dissolved in sterile phosphate buff-
ered saline (PBS), and delivered at a rate of 0.5µL/h via 
a subcutaneously implanted, pre-loaded mini-osmotic 
pump (Model 2002; Alzet), attached to a cannula target-
ing the injured dorsal aspect of the optic nerve. Prior to 
the study, the stability of YM872 in the presence of PBS 
was assessed by reverse phase High Performance Liquid 
Chromatography (HPLC), on a Waters BEH C18 column 
with 275  nm UV detection. No degradation of YM872 
dissolved in PBS was observed for 4 weeks at 37 °C. Simi-
lar analyses of oxATP showed some degradation after one 
day at 37 °C and almost complete degradation at 3 days, 
indicating that observed effects are due to the first day of 
oxATP treatment. Rats were housed individually to mini-
mise disturbance of mini-pumps by cage-mates. Controls 
included injured animals treated with vehicle only (PBS 
in pumps and/or oral butter vehicle) and completely nor-
mal animals.
Optokinetic nystagmus
At 2  days post-surgery, a cohort of rats (cohort 2: 8/
group, n = 48 animals) were anaesthetised as above and 
their uninjured left eye lids sutured shut. Following com-
plete recovery from anaesthesia (Day 3), behavioural 
testing was conducted using the optokinetic nystagmus 
test for visual function as described previously [50, 51]. 
Briefly, after acclimatisation, responses of rats to rotation 
of black and white stripes in the anti-clockwise direc-
tion were recorded. Analysis was performed by counting 
the number of purposeful movements in the direction of 
the stripes within the period each rat was engaged in the 
task.
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Tissue preparation
Tissue was collected from three separate cohorts of ani-
mals. Cohort 1 had 10 animals/group, total n = 30 ani-
mals, used for immunohistochemistry assessments of 
axonal changes at days 1 and 7 following injury, rela-
tive to normal control animals. Cohort 2 had 8 animals/
group, total n = 48 animals, used for behavioural analy-
ses and immunohistochemistry assessments of axonal 
and myelin structure following injury and treatment with 
ion channel inhibitor combinations or vehicle control, 
assessed at day 3. Cohort 3 had 5 animals/group, total 
n = 30, used for analyses of oxidative damage following 
injury and treatment with ion channel inhibitor combi-
nations or vehicle control, assessed at day 3. For cohort 
1 and 3, animals were euthanized with Euthal (Pentobar-
bitone sodium 850 mg/kg Phenytoin sodium 125 mg/kg; 
Delvet i.p.) and transcardially perfused with 0.9% NaCl 
followed by 4% paraformaldehyde (Sigma) in 0.1 M phos-
phate buffer, pH 7.2 (PFA). For cohort 2, animals were 
anaesthetised using ketamine–xylazil as described above, 
right optic nerves were dissected from the ocular cav-
ity, collected into a drop of optimal cutter temperature 
compound (Tissue-Tek, Sakura), on a microscope slide, 
quickly frozen over a bed of dry ice, then snap-frozen in 
Eppendorf microcentrifuge tubes in liquid nitrogen in 
accordance with optimal conditions required for immu-
nohistochemistry using specific node/paranode antibod-
ies (Neurofascins: note that staining was equivocal and 
is not described further), and stored in airtight zip-lock 
bags at −80 °C, to avoid desiccation.
Immunohistochemical assessments
Tissue was cryosectioned longitudinally at −20  °C 
(20 µm). Tissue from cohort 2 was fixed in 50:50 meth-
anol/acetone for 15  min (min), washed with PBS, post-
fixed for 1  min with Bouins solution and again washed 
with PBS prior to primary antibody application overnight 
at 4  °C. Immunohistochemical analyses were conducted 
according to established procedures [52], using primary 
antibodies recognising: manganese superoxide dismutase 
(MnSOD, 1:500; Abcam rabbit, SOD-110); DNA oxi-
dation indicator 8-hydroxyguanosine (8OHDG, 1:500; 
Abcam mouse Ab62623); advanced glycation end-prod-
uct carboxy-methyl lysine (CML, 1:500; CosmoBio, KAL-
KH024); lipid peroxidation products 4-hydroxynonenal 
(HNE, 1:200; Alpha Diagnostics, rabbit HNE11-S), and 
Acrolein (1:1000; Abcam, rabbit Ab37110); protein 
nitration indicator 3-nitrotyrosine (3NT, 1:500; Abcam 
mouse Ab61392); myelin basic protein (MBP, 1:500; 
Abcam, rabbit Ab40390 or Santa Cruz, goat SC13914); 
β-III tubulin (1:500; Covance, mouse MMS-435P); ED1 
for activated microglia/macrophages (CD68, 1:1000 
Merk Millipore, mouse MAB1435); Iba1 for resident 
microglia/macrophages (1:1000 Abcam, goat Ab5076); 
Caspr (1:500, Abcam, rabbit Ab34151 or NeuroMab 
mouse 75-001); and Ankyrin G (AnkG, 1:200; Invitro-
gen, mouse 33-8800) for paranode and node of Ranvier 
structures; axonal components Tau (1:400, Invitrogen, 
mouse AHB0042), Tau  p[S396] (1:200, Invitrogen rabbit 
44752G), Tau  p[S262] (1:400, Invitrogen, rabbit 44750G), 
Tau  p[T205] (1:200, Invitrogen, rabbit 44738G), acetylated 
α-tubulin (1:500, Sapphire, mouse Ab24610), and NogoA 
(1:400, Millipore, rabbit Ab5888); olig2 (1:500, R and D 
Systems, goat AF2418) and NG2 (1:400, Merck Millipore, 
rabbit Ab5320 or mouse MAB5384) to identify OPCs. 
Antibody binding was visualized following 2 h incubation 
at room temperature with appropriate Alexa Flour 488 
or 555 secondary antibodies (1:400; Molecular Probes, 
Life Technologies). Slides were cover-slipped using Fluo-
romount-G (Southern Biotechnology) and viewed using 
fluorescence microscopy.
Immunohistochemistry image analysis and quantification
Assessment of immunointensity in optic nerve sec-
tions was semi-quantitative, using established proce-
dures [6, 30], and in line with best practice [53], in order 
to assess cell-type specific changes with injury and ion 
channel inhibitor treatment. In brief: a single image of 
the area directly ventral to the primary injury site was 
visualized and photographed using either a Leitz Dia-
plan fluorescence microscope (Leica, Germany) where 
cellular colocalisation was not required e.g. for oxida-
tive stress measures, or a Nikon Eclipse Ti inverted 
microscope (Nikon Corporation) with a 20× objective 
or a 40×/1.3  N.A. oil immersion objective. For each 
outcome measure, all images were collected in a single 
session, with constant exposure and microscope set-
tings to ensure uniformity of imaging parameters and 
consistency between measures. When using the Nikon 
microscope, a series of optical images at 0.5  μm incre-
ments along the z-axis were acquired from the middle 
6 μm of each 20 μm section, sampling a field of view of 
217.5 × 162.5 μm (for 40× objective) of the ventral area, 
vulnerable to secondary degeneration. All images were 
collected using Nikon Elements AT software and decon-
voluted using autoquant blind deconvolution. Decon-
volution was performed using a custom written macro 
(Nathanael Yates) using the AQI_DeconvolutionND 
function and batch processing feature in NIS Elements. 
The images were then saved as new files for analy-
sis; investigators were blinded to image identity. Image 
analysis was performed using a custom written macro in 
ImageJ. Briefly, each image was opened, and the visual 
slice along the z axis that was most in focus was selected 
for analysis. The image was then cropped to standard 
dimensions (500 ×  500 pixel) in order to only include 
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the region of interest. The intensity above an arbitrary 
set threshold, and area above that threshold were meas-
ured with constant parameters for all files. Choice of 
threshold was based on a visual determination of the 
level that captured clearly immunopositive areas in a 
selection of images from all groups. Note that the degree 
of changes to outcomes did not change with the decon-
volution process. A range of normalisation techniques 
are employed in the literature to account for variation 
in tissue sections, and choice of these must be care-
fully considered in light of the outcome measure being 
assessed and the model and analyses employed. For 
immunohistochemical intensity and area data, such as 
in the current study, normalisation to background stain-
ing within the same section can be employed to account 
for variation in section thickness and antibody applica-
tion [54]. Here, all immunointensity data assessing cellu-
lar structures was normalised to background. Note that 
normalisation to background is not possible for oxida-
tive stress immunointensity data, as the oxidised pro-
teins and DNA are diffusely distributed throughout the 
cells and/or tissue and there is nowhere in the tissue that 
can be conclusively described as background. Following 
injury, it is not appropriate to normalise data relative to 
other proteins as these can change with the pathologi-
cal state. For example, β-III tubulin immunointensity 
increases at 3 days after injury [52]. As such, normalis-
ing to tubulin would result in inappropriate interpreta-
tion of data. The choice of data to display in histograms 
displaying immunointensity was based upon the pattern 
of immunoreactivity and whether changes occurred due 
to an increase in the area of immunofluorescence or an 
increase in the intensity of that immunofluorescence, as 
previously described [6]. For analyses of phosphorylated 
Tau (Tau p)  [S396], Tau  p[T205] or Tau  p[S262], the same 
area was used to analyse immunointensities, and data 
were expressed as a ratio of total Tau immunointensity.
For node/paranode analyses, 30 node/paranode com-
plexes were assessed from a single defined and consist-
ent field of view from a single z-series of images from 
each animal, collected as described above, measuring: 
the length of the paranodal gap, defined as the distance 
between two  Caspr+ paranodes [55]; the average length 
of the flanking paranodes  (Caspr+); and AnkG length/
distribution, defined as the length of  AnkG+ staining 
between flanking paranodes. A representative orthogo-
nal z-projection is shown to illustrate that the majority 
of node/paranode complexes did not span more than 
three visual slices; each z-stack was assessed to ensure 
inclusion of all elements of the node/paranode com-
plex within the visual sampling before analysis. Axons 
of the optic nerve are predominantly medium caliber 
(mean ±  SD =  0.64 ±  0.29) [56]; as such, the imaging 
strategy employed enabled detection of the majority of 
axons.  NG2+/olig2+ OPCs were identified by colocali-
sation of immunoreactivity and the number of OPCs 
in a single visual slice of a single image of ventral optic 
nerve for each animal, collected as described above, 
was counted. A single visual slice was utilised to ensure 
co-localisation of NG2 and olig2. Numbers of  ED1+ 
activated microglia/macrophages and  Iba1+ resident 
microglia were counted from a single visual slice of single 
images from both dorsal and ventral optic nerve for each 
animal, collected as described above.
Statistical analyses
Results were analysed using the statistical package Stat-
view for Windows (SAS Institute Inc.) or IBM SPSS 
Statistics. Equality of variance F-tests were conducted 
to test for homogeneity of variance in groups within 
experiments. Data were natural log transformed, where 
necessary to achieve a normal distribution. All data are 
expressed as means of each treatment group ±SEM, 
unless otherwise stated. ANOVAs followed by Dun-
nett’s or Games Howell post hoc tests as appropriate 
were used to statistically compare quantitative measures 
of each treatment group to the injured vehicle control. 
For selected outcomes of interest, multiple comparisons 
using Bonferroni post hoc tests were performed and 
noted in the Results text. ANOVA F-test and degrees 
of freedom (df ), as well as p value from post hoc tests 
are given. All statistical tests required p  ≤  0.05 for 
significance.
Results
Disruptions to axonal and oligodendrocyte proteins 
in secondary degeneration
Structural axonal and oligodendrocyte proteins were 
examined in ventral optic nerve vulnerable to secondary 
degeneration, following partial optic nerve transection. 
Note that the focus of the current study is on regions 
of the optic nerve vulnerable to secondary degenera-
tion, rather than areas directly impacted by the primary 
injury. A significantly higher ratio of immunoreactivity 
of Tau  p[S396] and Tau  p[T205] relative to total Tau was 
observed in ventral optic nerve at day 1 following injury 
(F = 16.03, df = 2, p ≤ 0.01 and F = 7.08, df = 2, p ≤ 0.01 
respectively), compared to normal optic nerve (Fig.  1a, 
c). While the ratio of Tau  p[S396] to total Tau remained 
significantly higher at day 7 (Fig.  1a, b; p ≤  0.001), the 
ratio of Tau  p[T205] to total Tau was significantly reduced 
(Fig. 1c; p ≤ 0.001), returning to normal optic nerve lev-
els. Changes in the ratio were driven by trends towards 
decreases in total Tau levels and increases in the levels 
of Tau phosphorylation, neither of which reached sta-
tistical significance (p  >  0.05). There was no significant 
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difference in the ratio of Tau  p[S262] relative to total Tau 
in ventral optic nerve (Fig. 1d; F = 2.59, df = 2, p > 0.05), 
nor differences in Tau  p[S262] immunoreactivity alone 
(p  >  0.05). Immunoreactivity of acetylated tubulin was 
also significantly elevated in optic nerve vulnerable to 
secondary degeneration at day 1 following injury, return-
ing to normal levels at day 7 (Fig. 1e, g; F = 16.49, df = 2, 
p  ≤  0.001). In contrast, NogoA immunoreactivity was 
significantly decreased at day 1 post injury in ventral 
optic nerve, and returned to normal levels at 7 days post 
injury (Fig. 1f, h; F = 13.79, df = 2, p ≤ 0.001).
No acute effects of ion channel inhibitor combinations 
on behavioural deficits
Partial optic nerve transection resulted in a signifi-
cant reduction in the number of optokinetic nystagmus 
responses at 3 days after injury (Fig. 2a; F = 2.54, df = 5, 
p  ≤  0.05). Despite a strong trend to increasing func-
tion with more inhibitors, treatment with a selection of 
combinations of ion channel inhibitors had no signifi-
cant effect on behavioural responses at this acute phase 
following injury, when compared to vehicle treated ani-
mals (p > 0.05), in contrast to our reported preservation 
Fig. 1 Indicators of cytoskeletal associated proteins assessed immunohistochemically in the ventral optic nerve at days 1 and 7 following partial 
transection (PT) injury. a The ratio of Tau  p[S396] to total Tau immunoreactivity was calculated using mean ± SEM area above set threshold for each 
protein and quantified from normal optic nerve and at days 1 and 7 following partial transection; b representative images from normal optic nerve 
shows Tau  p[S396] (green) and total Tau (red) with overlay, arrows indicate an example of co-localisation. c Similarly, the mean ± SEM ratio of Tau 
 p[T205] to total Tau; and d the ratio of Tau  p[S262] to total Tau ± SEM. e Mean ± SEM area above threshold of acetylated tubulin immunoreactivity; 
f mean ± SEM area above threshold of NogoA immunoreactivity. g, h Representative images from normal optic nerve show acetylated tubulin 
(red) and NogoA (green) respectively. Significant differences are indicated by *p < 0.05, **p < 0.01 and ***p < 0.001; b scale bar = 25 µm; g, h scale 
bar = 50 µm
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of visual function with the three inhibitors in combina-
tion at 3 months after injury [49]. Animals treated with 
more than one ion channel inhibitor made an intermedi-
ate number of responses, neither significantly improved 
above vehicle control nor different from normal animals 
(p > 0.05). Note that throughout the current study, out-
comes of the different treatment combinations are not 
compared to each other. Furthermore, no detrimental 
effects of the inhibitor combination on animal welfare 
were observed.
Effects of ion channel inhibitors on axonal 
and oligodendrocyte proteins
Similarly to findings at day 1 after injury, the ratios of 
Tau  p[S396] and Tau  p[T205] relative to total Tau in ven-
tral optic nerve vulnerable to secondary degeneration 
were significantly increased at day 3 following injury, 
compared to normal optic nerve (Fig.  2b, c; F  =  9.06, 
df =  5, p ≤  0.001 and F =  12.39, df =  5, 33, p ≤  0.001 
respectively). All tested ion channel inhibitor combina-
tions significantly reduced immunoreactivity of both Tau 
 p[S396] and  p[T205] expressed as a ratio of total Tau, when 
compared to vehicle treated animals (Fig. 2b, c; p ≤ 0.05); 
changes in pTau or total Tau alone were not significant 
(p > 0.05). Immunoreactivity of Tau  p[S262] was not sig-
nificantly altered at day 3 following injury, and there were 
no significant differences with ion channel inhibitors.
Similarly to findings at day 1 after injury, the immuno-
reactivity of acetylated tubulin was significantly elevated 
in vehicle treated animals 3 days post injury, compared to 
normal optic nerve (Fig. 2d; F = 8.80, df = 5, p ≤ 0.01). 
The combinations of Lom/oxATP and the three inhibi-
tors significantly reduced acetylated tubulin immunore-
activity (p ≤ 0.01): Lom and Lom + YM872 resulted in 
maintenance of significantly elevated acetylated tubulin 
immunoreactivity above normal (p ≤ 0.01). There was a 
Fig. 2 Mean ± SEM responses in the optokinetic nystagmus test of visual function and immunoreactivity of axonal and oligodendrocyte proteins, 
3 days following partial transection of the optic nerve. a Total number of smooth pursuits and fast resets/minute engaged in the task by normal, or 
injured vehicle or inhibitor treated animals. b Effects of injury ± combinations of ion channel inhibitors on ratio of Tau  p[S396] to total Tau and c ratio 
of Tau  p[T205] to total Tau immunoreactivities were calculated using mean ± SEM area above an arbitrarily set threshold for each protein. Similarly,  
d mean ± SEM area above threshold of acetylated tubulin, e NogoA and f mean ± SEM intensity above threshold of MBP immunoreactivity.  
Significant differences compared to vehicle are indicated by *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001
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significant decrease in NogoA immunoreactivity in ven-
tral optic nerve from vehicle treated animals, compared 
to normal optic nerve (Fig. 2e; F = 9.59, df = 5, p ≤ 0.05). 
Treatment of animals with all combinations of inhibitors 
significantly increased immunoreactivity of NogoA above 
vehicle treated animals (p ≤ 0.001). Interestingly, multi-
ple comparison tests revealed that treatment with the 
triple combination of ion channel inhibitors resulted in 
significant upregulation of the expression of NogoA com-
pared to normal nerve (Fig. 2e; p ≤ 0.02). There was a sig-
nificant increase in MBP immunostaining intensity 3 days 
after injury in vehicle treated animals (Fig. 2f; F = 3.46, 
df = 5, p ≤ 0.05). Following treatment with selected ion 
channel inhibitor combinations, intermediate effects 
were observed, with only Lom, and Lom + oxATP treat-
ments resulting in significant decreases compared to 
vehicle treated animals (Fig. 2f, p ≤ 0.05).
Effects of ion channel inhibitor combinations on structure 
of the node of Ranvier complex
Structural parameters of the nodes of Ranvier and of 
paranodes were quantified in ventral optic nerve, and 
the effects of the selected combinations of ion chan-
nel inhibitors assessed. Note that analysis is confined 
to node/paranode structures able to be visualised using 
the imaging parameters employed, likely to include 
those associated with the majority of optic nerve axons 
[56]. Both the paranodal gap (F = 4.19, df = 5, p ≤ 0.05) 
and the average paranodal length (F  =  3.12, df  =  5, 
p ≤  0.05) were significantly increased 3  days following 
injury compared to normal nerve (Fig.  3a, b, d). All of 
the tested ion channel inhibitor combinations resulted 
in significantly decreased paranodal gaps in ventral optic 
nerve, compared to vehicle treated animals (Fig.  3a, d; 
p ≤  0.05). Similarly, most ion channel inhibitor combi-
nations resulted in decreased paranode lengths (Fig. 3b, 
d; p  ≤  0.05); although outcomes following treatment 
with Lom + YM872 were not significantly different from 
vehicle treated animals or normal (Fig. 3b; p > 0.05). The 
average length of AnkG immunoreactivity at the node 
of Ranvier was significantly increased 3  days follow-
ing injury, compared to normal (Fig.  3c, d; F =  15.237, 
df =  5, p ≤  0.05), indicating a spread of  Na+ channels 
in optic nerve vulnerable to secondary degeneration. 
Following treatment with selected ion channel inhibi-
tor combinations, intermediate effects of Lom + YM872 
and Lom + oxATP were observed, with only treatment 
with Lom +  oxATP +  YM872 resulting in significantly 
decreased lengths of AnkG immunoreactivity compared 
to vehicle treated animals (Fig. 3c, d; p ≤  0.05). A rep-
resentative orthogonal z-projection from normal optic 
nerve is shown (Fig.  3e): all node/paranode complexes 
assessed fell within the visual sampling.
Effects of ion channel inhibitor combinations on microglia/
macrophage numbers
The numbers of  ED1+ activated microglia/macrophages 
and  Iba1+ resident microglia/macrophages were quanti-
fied in both dorsal optic nerve directly impacted by the 
injury and ventral optic nerve vulnerable to second-
ary degeneration, as macrophage derived reactive spe-
cies from dorsal nerve are thought to trigger secondary 
degeneration [6]. The numbers of  ED1+ and  Iba1+ 
cells were increased following injury, in both dorsal 
and ventral aspects of the optic nerve, as expected [52] 
(F =  13.902, F =  14.79 respectively, df =  5, p ≤  0.05). 
However, there were no significant effects of any of the 
inhibitor combinations on numbers of  ED1+ or  Iba1+ 
microglia/macrophage (Table 1, p > 0.05).
Effects of ion channel inhibitor combinations on oxidative 
stress indicators and OPCs
An increase in the immunopositive areas of lipid per-
oxidation product acrolein (Fig.  4a, c; F =  2.57, df =  5, 
p ≤ 0.05) was observed in optic nerve of vehicle treated 
animals 3  days following partial transection. This was 
associated with a significant decrease in the number of 
 Olig2+/NG2+ OPCs (Fig. 4d; F = 4.03, df = 5, p ≤ 0.05). 
There was no significant effect of injury on immunointen-
sity of the lipid peroxidation indicator HNE at three days 
following injury (Fig.  4b, c; F =  2.86, df =  5, p  >  0.05). 
However, HNE was significantly reduced following treat-
ment with Lom +  OxATP +  YM872 (p ≤  0.05): other 
inhibitor combinations were not significantly differ-
ent from vehicle treated animals or normal (p  >  0.05). 
Similarly, only treatment with Lom + OxATP + YM872 
significant increased OPC numbers relative to vehicle 
control (Fig.  4d; p ≤  0.05; Fig.  4e shows representative 
images of OPCs). There was an intermediate effect of all 
combinations of ion channel inhibitors on acrolein, with 
no statistically significant difference between normal or 
injured vehicle treated nerve with any ion channel inhibi-
tor treatment group (Fig. 4a, p > 0.05).
Significant increases in the mean intensity of immu-
noreactivity of DNA oxidation marker 8OHDG (Fig. 5a, 
e; F =  3.82, df =  5, p ≤  0.05), advanced glycation end-
product CML (Fig.  5b, f; F  =  2.27, df  =  5, p  ≤  0.05), 
protein nitration indicator 3NT (Fig.  5c, g; F  =  5.23, 
df  =  5, p  ≤  0.05) and antioxidant enzyme MnSOD 
(Fig.  5d, h; F =  2.33; df =  5, p ≤  0.05) were observed 
in optic nerve vulnerable to secondary degeneration, 
3  days following partial transection. MnSOD immuno-
reactivity displayed a punctate pattern, likely reflect-
ing aggregates of cellular debris as previously described 
[50]. Following treatment with the selected ion chan-
nel inhibitor combinations, no significant reductions 
in 8OHDG or CML were observed, relative to vehicle 
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Fig. 3 Effects of combinations of ion channel inhibitors on node/paranode complexes. Mean ± SEM a length of the paranodal gap, indicative of 
node length; b paranode length and c  AnkG+ length were quantified from normal, or injured vehicle or inhibitor treated animals, 3 days following 
partial optic nerve transection. Significant differences relative to vehicle are indicated by *p ≤ 0.05. d Representative images show Caspr immuno-
positive paranodes (green) and AnkG immunopositive structures within the node of Ranvier (red); scale bar = 5 µm. e A representative orthogonal 
z-projection of Caspr immunopositive paranodes (green) and AnkG immunopositive structures within the node of Ranvier (red) from normal ventral 
optic nerve; scale bar = 5 µm
Table 1 Numbers of  ED1+ and  Iba1+ microglia/macrophages in dorsal and ventral optic nerve following partial transection
Mean ± SEM numbers of  ED1+ and  Iba1+ cells within the field of view; significant differences relative to vehicle are indicated by * p ≤ 0.05
Normal Vehicle Lom Lom/YM872 Lom/oxATP Lom/oxATP/YM872
ED1
Dorsal 5.4 ± 0.8 34.5 ± 11.2* 33.5 ± 10.5 29.0 ± 5.8 47.0 ± 11.3 38.6 ± 11.0
Ventral 5.0 ± 1.1 22.5 ± 5.5* 16.8 ± 4.9 26.1 ± 8.6 32.0 ± 9.5 33.2 ± 9.7
Iba1
Dorsal 5.2 ± 1.0 19.2 ± 4.5* 21.1 ± 4.9 29.6 ± 3.6 32.8 ± 4.7 29.2 ± 3.9
Ventral 4.8 ± 1.0 14.1 ± 1.7* 9.5 ± 2.7 27.4 ± 6.8 24.8 ± 4.7 28.9 ± 4.4
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Fig. 4 Effects of combinations of  ion+ channel inhibitors on oxidative stress and oligodendrocyte progenitor cells (OPCs). Mean ± SEM area above 
an arbitrarily set threshold a acrolein and b HNE immunointensity above an arbitrarily set threshold, in ventral optic nerve from normal, or injured 
vehicle or ion inhibitor treated animals, 3 days following partial optic nerve transection. Significant differences relative to vehicle are indicated by 
*p ≤ 0.05. c Representative images of acrolein and HNE immunointensity are shown; scale bar = 50 µm. d Mean ± SEM oligodendrocyte progeni-
tor cell (OPC) counts in ventral optic nerve from normal, or injured vehicle or inhibitor treated animals, 3 days following partial transection. e Repre-
sentative images illustrating OPC identification as  NG2+/olig2+ cells; scale bar = 5 µm
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Fig. 5 Effects of combinations of ion channel inhibitors on additional indicators of oxidative stress. Mean ± SEM intensity above an arbitrarily set 
threshold for a 8-hydroxy-2′deoxyguanosine (8OHDG); b Carboxymethyl lysine (CML); and mean ± SEM area above an arbitrarily set threshold 
for c 3-nitrotyrosine (3NT); or d manganese superoxide dismutase (MnSOD) immunoreactivity were quantified at 3 days following partial optic 
nerve transection, in ventral optic nerve of normal, or injured vehicle or treated animals. Significant differences relative to vehicle are indicated by 
*p ≤ 0.05. Representative images of e 8OHDG, f CML, g 3NT and h MnSOD immunoreactivity in normal and injured vehicle or inhibitor treated 
ventral nerve, 3 days following partial transection; scale bars = 50 μm
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treated animals (Fig.  5a, b, p  >  0.05). Only Lom treat-
ment significantly reduced 3NT immunoreactivity, 
whereas both Lom and Lom + OxATP + YM872 treat-
ment reduced MnSOD immunoreactivity (Fig.  5c, d; 
p ≤ 0.05). For 8OHDG, all inhibitor combinations other 
that Lom  +  YM872  +  oxATP remained significantly 
increased from normal (p ≤ 0.05); other inhibitor combi-
nations resulted in an intermediate effect for CML, 3NT 
and MnSOD, not significantly different from normal or 
vehicle (p > 0.05).
Discussion
Changes in  Ca2+ dynamics during secondary degen-
eration have been shown to be associated with oxida-
tive stress and disruptions to myelin structure. Here we 
demonstrate acute increases in Tau protein phosphoryla-
tion, tubulin acetylation and decreases in NogoA in optic 
nerve exclusively vulnerable to secondary degeneration. 
Combinations of ion channel inhibitors were used as 
a tool to dissect out which ion channels are important 
for influx of extracellular ions associated with the dis-
ruptions of secondary degeneration. It was found that 
inhibition of most ion channel combinations assessed, 
including VGCCs alone, led to restoration of the normal 
lengths of the paranodal gap, and paranode and normal 
levels of phosphorylated Tau and NogoA. However, only 
inhibition of VGCCs,  P2X7Rs and AMPARs together, 
significantly restored AnkG length at the nodes of Ran-
vier to normal, limited HNE immunoreactivity and pre-
vented OPC loss (see summary of outcomes in Table 2). 
Inhibition of all three ion channels also leads to long term 
preservation of visual function in this model [49], imply-
ing an important role for these latter components of the 
injury response in chronic deficits.
Increased Tau phosphorylation reduces the binding of 
Tau to microtubules in intact neurons [57] and phospho-
rylation of Tau at  [S396] reduces its affinity for and abil-
ity to stabilize microtubules [58]. While it is important 
to note that the number of specific phosphorylation sites 
recognised with the phosphorylation dependent antibod-
ies we have used is limited, with over 25 phosphoryla-
tion sites in Tau that are associated with disease or injury 
[59] not assessed in the current study, some relation-
ships can be explored. We observed no changes in the 
ratio of phosphorylated Tau at  [S262] in tissue vulnerable 
to secondary degeneration, but other isoforms exhibited 
increased phosphorylated Tau. Tau phosphorylation spe-
cifically at  [S262] has been reported to be independent of 
 Ca2+ whereas phosphorylation of other Tau proteins is 
 Ca2+ dependent [60]. Taken together, this suggests that 
the observed changes in Tau phosphorylation associated 
with secondary degeneration are induced by  Ca2+ influx. 
The importance of  Ca2+ influx in Tau phosphoryla-
tion in secondary degeneration is further supported by 
Table 2 Summary of  outcomes following  partial transection injury and  treatment with  combinations of  ion channel 
inhibitors to inhibit VGCCs,  Ca2+ permeable AMPARs and/or  P2X7Rs at 3 days after injury
Symbols for vehicle treated animals indicate direction of change from normal untreated animals. Following treatment with ion channel inhibitors, significant 
decreases relative to injured animals treated with vehicle are shown as ↓, significant increases as ↑, remaining significant differences to normal are indicated by—
(p ≤ 0.05) and intermediate outcomes not significantly different from vehicle treated or normal as ~(p > 0.05)





 Visual function ↓ ~ ~ ~ ~
 Tau[pS396]/total Tau ↑ ↓ ↓ ↓ ↓
 Tau[pT205]/total Tau ↑ ↓ ↓ ↓ ↓
 Acetylated tubulin ↑ – – ↓ ↓
 NogoA ↓ ↑ ↑ ↑ ↑
 MBP ↑ ↓ ~ ↓ ~
 Paranodal gap length ↑ ↓ ↓ ↓ ↓
 Paranode length ↑ ↓ ~ ↓ ↓
 Ankyrin G length ↑ – ~ ~ ↓
 Microglia/macrophages ↑ ~ ~ ~ ~
 Acrolein ↑ ~ ~ ~ ~
 HNE ~ ~ ~ ~ ↓
 OPCs ↓ ~ ~ ~ ↑
 8OHDG ↑ ↑ ↑ ↑ ~
 CML ↑ ~ ~ ~ ~
 3NT ↑ ↓ ~ ~ ~
 MnSOD ↑ ↓ ~ ~ ↓
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our findings of restored ratios of phosphorylated Tau to 
total Tau at  [S396] and  [T205] following treatment with all 
tested combinations of ion channel inhibitors. However, 
limiting flux of other ions such as  Na+ through  P2X7R 
and  Ca2+ permeable AMPAR may also have contributed 
to observed effects. We have recently demonstrated that 
of the tested combinations of ion channel inhibitors, the 
Lom + YM872 and Lom + OxATP + YM872 combina-
tions significantly reduced intracellular  Ca2+ concentra-
tions in mixed cortical cultures exposed to  H2O2 insult 
[61]. While the in vitro environment is very different to 
the injured nerve in vivo and results are not directly com-
parable, it is likely that limiting excess  Ca2+ flux is con-
tributing to beneficial outcomes for phosphorylated Tau 
and other measures. Acetylated tubulin increases have 
been linked to calcium changes and may reflect increased 
axonal stability [62] in optic nerve vulnerable to sec-
ondary degeneration, although this is not supported by 
observed increases in Tau phosphorylation. The restora-
tion of normal tubulin acetylation only by two or three 
ion channel inhibitors together, likely reflects restored 
ionic homeostasis. Nogo-A inhibits axonal extension and 
has been shown to decrease early after spinal cord injury, 
followed by later increases [38]. Similarly, we observed 
an acute decrease in NogoA immunoreactivity, which 
was prevented by all of the ion channel inhibitor com-
binations, indicating a generalised role for maintenance 
of intracellular ionic homeostasis in NogoA responses. 
Taken together, the data show that specific elements 
of axonal stability are regulated to differing degrees by 
altered ionic homeostasis.
An increase in the length of the node of Ranvier has 
been observed in many pathologies including multiple 
sclerosis [55], glutamate excitotoxicity [63], hyperoxia 
[64]; and spinal cord injury [65, 66]. It has been suggested 
that this lengthening may be due to myelin retraction and 
a breakdown of the paranodal junction [63, 67]. The node 
lengthens, whilst maintaining normal paranodal and jux-
taparanodal structure, due to insertion of more mem-
brane at the node [68]. Along the myelinated axon, an 
appreciable amount of  Ca2+ influx is due to VGCCs, nor-
mally located and controlled at the axolemma [69, 70]. 
When the axolemma in these regions are exposed due 
to myelin retraction and splitting at paranodal regions, 
excessive influx of  Ca2+ through axonal L-type VGCCs 
may occur [71]. Lomerizine inhibition of VGCCs, known 
to be present on myelinating mature oligodendrocytes 
[72], is associated with restoration of paranode structure. 
Inhibition of VGCCs, together with shielding of these 
channels by myelin, likely contributes to reduced  Ca2+ 
mediated activation of Tau phosphorylation [60].
A generalised increase in MBP immunoreactivity 
was observed in optic nerve vulnerable to secondary 
degeneration, as previously described [52]. Increased 
MBP immunoreactivity has been shown to reflect a 
release of MBP into the surrounding milieu, followed by 
upregulated expression of MBP mRNA and protein [73], 
and/or conformational changes [74]. It is not yet clear 
why only Lom, and Lom +  oxATP treatments resulted 
in reduced MBP immunoreactivity whereas other com-
binations of inhibitors did not. Disruption of myelin can 
cause increases in NG2 immunopositive cells [75]; how-
ever we have observed decreases in  NG2+/olig2+ OPCs 
acutely in the current study, and chronically [34]. OPC 
depletion can be due to the cytotoxic action of the lipid 
peroxidation product 4-HNE on OPCs [76], supported 
by the observation that reductions in HNE via treatment 
with the three inhibitors in combination decreased both 
HNE immunoreactivity and the loss of OPCs in nerve 
vulnerable to secondary degeneration. HNE is both a 
product of lipid peroxidation and a toxic metabolite, 
observed to increase in optic nerve vulnerable to second-
ary degeneration [6]. While HNE was not significantly 
increased compared to normal in the current study, the 
reduction with treatment with the three inhibitors indi-
cates a shift in the balance of oxidative metabolism below 
normal homeostasis and may reflect a compensatory 
response. 4-HNE treatment increases intracellular  Ca2+ 
levels [77] and 4-HNE is toxic to axons and oligodendro-
cytes [78], covalently binding cytoskeletal proteins [79, 
80], disrupting cytoskeletal structure [81], conjugating 
proteins [82, 83], and inhibiting mitochondrial respira-
tion [83]. The associative relationship between the pro-
tection of OPCs and reduction in HNE immunoreactivity 
as a consequence of inhibiting VGCCs,  P2X7Rs and  Ca2+ 
permeable AMPARs, supports the importance of influx 
of extracellular  Ca2+ and associated lipid peroxidation in 
OPC vulnerability. OPCs are reported to be particularly 
vulnerable to oxidative damage, with maturation depend-
ent vulnerability [33] and a lack of intrinsic antioxidants 
[84]. Indeed, we do not observe either acute or chronic 
loss of mature  CC1+ oligodendrocytes in this model [34]. 
Acrolein elimination requires GSH, inherently low in 
OPCs [84], which may explain why the lipid peroxidation 
indicator acrolein was not similarly reduced. Intermedi-
ate effects of ion channel inhibition were observed with 
a range of other elements of oxidative damage, indicat-
ing complex contributions of ions including  Ca2+ to gen-
eration of reactive species and subsequent secondary 
degeneration.
The preservation of OPC numbers observed in the cur-
rent study may have been due to increased proliferation 
above the baseline proliferative response to the injury that 
we have already reported [34], or reduced OPC death, and 
further studies will be required to investigate this mecha-
nism. OPCs are thought to contact axons at the node of 
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Ranvier and contribute to Na channel clustering [85]. In 
the current study, a continued spread of sodium channels, 
indicated by AnkG immunoreactivity [86] was observed, 
even when paranode structure was preserved by the less 
effective combinations of ion channel inhibitors. Our 
working hypothesis is that the protection of OPCs may 
contribute to AnkG clustering as a specific consequence 
of limiting HNE with the multiple ion channel inhibitors, 
thereby contributing to observed long term preserva-
tion of function [49]. The lack of significant preservation 
of acute function following treatment with various com-
binations of ion channel inhibitors, is associated with 
increased microglia/macrophages and alterations in MBP 
and selected oxidative stress indicators, some of which 
resolve as time passes [49].  Ca2+ influx modulated by 
Na ions and Na influx independent of  Ca2+ [69, 87] may 
also contribute to acute pathology. In addition, potas-
sium channels such as Kv2.1 can regulate  Ca2+ influx [88] 
and have been shown to be oxidised following traumatic 
brain injury [89], which may further influence ionic flux. 
Internal  Ca2+ stores released via ryanodine and inositol 
triphosphate receptors may also contribute to secondary 
degeneration [90]; ryanodine receptors are also oxidised 
by reactive species, thus leaking  Ca2+, and likely fur-
ther contributing to pathology [91]. Visual responses are 
affected by secondary degeneration of the ventral optic 
nerve. Protection of ventral degeneration can preserve 
visual function at normal levels, as assessed by both the 
optokinetic nystagmus and Y-maze pattern recognition 
task [49, 92], and despite axotomy of dorsal axons. It is 
likely that the disparity between acute visual deficits and 
chronic visual function rescue reflects transient disrup-
tions to axonal transport and function that were later res-
cued with the combination of three inhibitors.
Conclusions
Using ion channel inhibitors as a tool has allowed 
increased understanding of the multiple components of 
pathology that contribute to the acute phase of secondary 
degeneration.
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